Akili Q1 2024 Adj EPS $(0.12) Beats $(0.14) Estimate, Sales $383.00K Miss $794.00K Estimate

Akili (NASDAQ:AKLI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 29.41 percent increase over losses of $(0.17) per sh

BenzingaMay 14 16:41 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersArcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. As per the press release, Q1

BenzingaMay 14 16:31 ET

Express News | Akili Evaluates Potential Strategic Alternatives

BenzingaMay 14 16:24 ET

Akili | 10-Q: Quarterly report

SEC announcementMay 14 16:24 ET · Announcements

Akili 1Q Rev $383,000 >AKLI

Akili 1Q Rev $383,000 >AKLI

Dow JonesMay 14 16:05 ET

Earnings Flash (AKLI) AKILI Posts Q1 Revenue $383,000, Vs. Street Est of $0.8M

04:03 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (AKLI) AKILI Posts Q1 Revenue $383,000, vs. Street Est of $0.8M

MT NewswiresMay 14 16:03 ET